EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality

Eli Zolotov, Anat Sigal, Martin Havrda, Maria Raskova, David Girsa, Uri Hochfeld, Karolína Krátká, Ivan Rychlík

Kidney and Blood Pressure Research · 2023

DOI: 10.1159/000530803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, 2023. Verfasst von Eli Zolotov und 7 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hackensack University Medical Center, Hackensack, New Jersey, USA, elizolotov@gmail.com. Hauptthemen laut MEDLINE: COVID-19, Acute Kidney Injury, Renal Insufficiency, Chronic. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The main objective of this study was to identify the best combination of admission day parameters for predicting COVID-19 mortality in hospitalized patients. Furthermore, we sought to compare the predictive capacity of pulmonary parameters to that of renal parameters for mortality from COVID-19.

Methods

In this retrospective study, all patients admitted to a tertiary hospital between September 1st, 2020, and December 31st, 2020, who were clinically symptomatic and tested positive for COVID-19, were included. We gathered extensive data on patient admissions, including laboratory results, comorbidities, chest X-ray (CXR) images, and SpO2 levels, to determine their role in predicting mortality. Experienced radiologists evaluated the CXR images and assigned a score from 0 to 18 based on the severity of COVID-19 pneumonia. Further, we categorized patients into two independent groups based on their renal function using the RIFLE and KDIGO criteria to define the acute kidney injury (AKI) and chronic kidney disease (CKD) groups. The first group (“AKI&CKD”) was subdivided into six subgroups: normal renal function (A); CKD grade 2+3a (B); AKI-DROP (C); CKD grade 3b (D); AKI-RISE (E); and grade 4 + 5 CKD (F). The second group was based only on estimated glomerular filtration rate (eGFR) at the admission, and thus it was divided into four grades: grade 1, grade 2+3a, grade 3b, and grade 4 + 5.

Results

The cohort comprised 619 patients. Patients who died during hospitalization had a significantly higher mean radiological score compared to those who survived, with a p value <0.01. Moreover, we observed that the risk for mortality was significantly increased as renal function deteriorated, as evidenced by the AKI&CKD and eGFR groups (p < 0.001 for each group). Regarding mortality prediction, the area under the curve (AUC) for renal parameters (AKI&CKD group, eGFR group, and age) was found to be superior to that of pulmonary parameters (age, radiological score, SpO2, CRP, and D-dimer) with an AUC of 0.8068 versus 0.7667. However, when renal and pulmonary parameters were combined, the AUC increased to 0.8813. Optimal parameter combinations for predicting mortality from COVID-19 were identified for three medical settings: Emergency Medical Service (EMS), the Emergency Department, and the Internal Medicine Floor. The AUC for these settings was 0.7874, 0.8614, and 0.8813, respectively.

Conclusions

Our study demonstrated that selected renal parameters are superior to pulmonary parameters in predicting COVID-19 mortality for patients requiring hospitalization. When combining both renal and pulmonary factors, the predictive ability of mortality significantly improved. Additionally, we identified the optimal combination of factors for mortality prediction in three distinct settings: EMS, Emergency Department, and Internal Medicine Floor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Acute Kidney InjuryRenal Insufficiency, ChronicHumansPrognosisRetrospective StudiesLungRisk FactorsHospital Mortality

Stichwörter der Autor:innen

Acute kidney injuryCOVID-19Chronic kidney diseaseEstimated glomerular filtration rateLung diseaseMortality predictionPrognosis

Autor:innen und Institutionen

  • Internal Medicine Department, Hackensack University Medical Center, Hackensack, New Jersey, USA, elizolotov@gmail.com.
  • Third Faculty of Medicine, Charles University, Prague, Czechia, elizolotov@gmail.com.
  • Third Faculty of Medicine, Charles University, Prague, Czechia.
  • Pediatrics Department, Hackensack University Medical Center, Hackensack, New Jersey, USA.
  • Department of Internal Medicine, Faculty Hospital Královské Vinohrady, Prague, Czechia.
  • Department of Radiology, Faculty Hospital Královské Vinohrady, Prague, Czechia.

Zitieren

APA

Zolotov, E., Sigal, A., Havrda, M., Raskova, M., Girsa, D., Hochfeld, U., Krátká, K., & Rychlík, I. (2023). Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality. Kidney and Blood Pressure Research. https://doi.org/10.1159/000530803

Vancouver

Zolotov E, Sigal A, Havrda M, Raskova M, Girsa D, Hochfeld U, et al. Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality. Kidney and Blood Pressure Research. 2023. doi:10.1159/000530803

BibTeX
@article{Zolotov2023,
  author = {Zolotov, Eli and Sigal, Anat and Havrda, Martin and Raskova, Maria and Girsa, David and Hochfeld, Uri and Krátká, Karolína and Rychlík, Ivan},
  title = {Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality},
  journal = {Kidney and Blood Pressure Research},
  year = {2023},
  doi = {10.1159/000530803}
}
Kostenlos starten →